4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

CAS No.
6674-17-5
CCD No.
CCD00583209
Formula
C9 H8 Cl N3 O
MolWeight
209.635

Company information Contact Business Type Country/Region Inquiry

Shanghai Arkpharm Limited

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

+86 21 20250286

http://www.arkpharm.com

Trading Company
China Inquiry

StruChem Co., Ltd.

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

51263009836

http://www.struchem.com

Trading Company
China Product inquiry 6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE on chemcd. Inquiry

Chemieliva Pharmaceutical Co., Ltd.

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

86 2367770219

http://www.chemieliva.com

Trading Company
China Inquiry

Suzhou Rovathin Foreign Trade Co., Ltd.

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

+86 512 65816829, 61978430, 60635156

http://www.rovathin.com.cn

Trading Company
China Inquiry

Shanghai Specbiochem CO., LTD.

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

+86 21 5132 0052

http://www.specbiochem.com

Trading Company
China Inquiry

Ablock Pharmatech, Inc.

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

609 751 5796

http://www.ablockpharmatech.com

Trading Company
United States Inquiry

Facus Pharmaceutical Co.,Ltd.

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

86 (0) 574 62378411

http://www.facus-pharma.com

Trading Company
China Inquiry

Win-leader Biotechnology Co., Ltd.

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

886 3 6587171

http://www.win-leaderpharm.com

Trading Company
China Inquiry

Arking Pharma Scientific Inc.

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

519 829 0818

http://www.arkingpharm.com

Trading Company
Canada Inquiry

Wonda Science

6674-17-5, 4-(5-CHLOROMETHYL-[1,2,4]OXADIAZOL-3-YL)-ANILINE

514 581 6866

http://www.wondasci.com

Trading Company
Canada Inquiry

* If the product has intellectual property rights, a license granted is must or contact us.